Risk of myocardial infarction, heart failure, and cerebrovascular disease with the use of valsartan, losartan, irbesartan, and telmisartan in patients

There is a lack of studies comparing the risk of cardio-cerebrovascular disease between angiotensin receptor blockers (ARBs) of different half-lives. We aimed to compare the risks of myocardial infarction (MI), heart failure (HF), and cerebrovascular disease with the use of valsartan, losartan, irbe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Yung-Geun, Lim, Min-Jung, Kim, Jin-Seob, Jeong, Han-Eol, Ko, HeeJoo, Shin, Ju-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659604/
https://www.ncbi.nlm.nih.gov/pubmed/37986329
http://dx.doi.org/10.1097/MD.0000000000036098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659604/
https://www.ncbi.nlm.nih.gov/pubmed/37986329
http://dx.doi.org/10.1097/MD.0000000000036098

Ejemplares similares